Compare CNC & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNC | IFF |
|---|---|---|
| Founded | 1984 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 18.1B |
| IPO Year | 2001 | 2010 |
| Metric | CNC | IFF |
|---|---|---|
| Price | $48.68 | $70.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $40.56 | ★ $89.09 |
| AVG Volume (30 Days) | ★ 3.9M | 1.3M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $194,777,000,000.00 | N/A |
| Revenue This Year | $8.31 | N/A |
| Revenue Next Year | $1.05 | $3.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.44 | N/A |
| 52 Week Low | $25.08 | $59.14 |
| 52 Week High | $63.42 | $84.45 |
| Indicator | CNC | IFF |
|---|---|---|
| Relative Strength Index (RSI) | 82.05 | 44.43 |
| Support Level | $33.00 | $68.35 |
| Resistance Level | N/A | $75.07 |
| Average True Range (ATR) | 1.56 | 1.87 |
| MACD | 1.16 | -0.15 |
| Stochastic Oscillator | 99.16 | 13.99 |
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest this business in the future.